Dapagliflozin-3-O-β-D-Glucuronide

Suppliers

Names

[ CAS No. ]:
1351438-75-9

[ Name ]:
Dapagliflozin-3-O-β-D-Glucuronide

[Synonym ]:
Dapagliflozin-3-O-β-D-Glucuronide
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-3-O-β-D-glucopyranuronosyl-, (1S)-
(1S)-1,5-Anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-3-O-β-D-glucopyranuronosyl-D-glucitol
DAPAGLIFLOZIN 3-O-GLUCURONIDE

Chemical & Physical Properties

[ Density]:
1.6±0.1 g/cm3

[ Boiling Point ]:
857.0±65.0 °C at 760 mmHg

[ Molecular Formula ]:
C27H33ClO12

[ Molecular Weight ]:
584.997

[ Flash Point ]:
472.1±34.3 °C

[ Exact Mass ]:
584.166077

[ LogP ]:
1.55

[ Vapour Pressure ]:
0.0±0.3 mmHg at 25°C

[ Index of Refraction ]:
1.666


Related Compounds

  • DiosMetin 3-O-β-D-Glucuronide
  • Equilin 3-O-β-D-Glucuronide Sodium Salt
  • Naltrexone 3-O-β-D-Glucuronide
  • cis-Resveratrol 3-O-β-D-Glucuronide
  • Dihydro Isoferulic Acid 3-O-β-D-Glucuronide
  • chloramphenicol glucuronide
  • (2Z)-2-[(3-chlorophenyl)imino]-5-(hydroxymethyl)-8-methyl-2H-pyrano[2,3-c]pyridine-3-carbothioamide
  • (E)-N-(4-chlorobenzylidene)-8-methyl-2-phenyl-2,4-dihydrochromeno[2,3-c]pyrazol-3-amine
  • (E)-N-(3-fluorobenzylidene)-8-methyl-2-phenyl-2,4-dihydrochromeno[2,3-c]pyrazol-3-amine
  • (E)-8-methyl-N-(4-methylbenzylidene)-2-phenyl-2,4-dihydrochromeno[2,3-c]pyrazol-3-amine
  • 1-[2-(2-Aminophenoxy)ethyl]-4,6-dimethyl-2(1H)-pyrimidinone
  • (E)-8-methyl-2-phenyl-N-(4-(trifluoromethyl)benzylidene)-2,4-dihydrochromeno[2,3-c]pyrazol-3-amine
  • (E)-N-(4-fluorobenzylidene)-8-methyl-2-phenyl-2,4-dihydrochromeno[2,3-c]pyrazol-3-amine
  • (E)-N-(2-methoxybenzylidene)-8-methyl-2-phenyl-2,4-dihydrochromeno[2,3-c]pyrazol-3-amine
  • (E)-N-benzylidene-8-methyl-2-phenyl-2,4-dihydrochromeno[2,3-c]pyrazol-3-amine
  • (E)-N-(2-chlorobenzylidene)-8-methyl-2-phenyl-2,4-dihydrochromeno[2,3-c]pyrazol-3-amine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.